Assessment of implant retention and alteration of the gums in early/ late implant placement among smokers
- Conditions
- Health Condition 1: Z915- Personal history of self-harm
- Registration Number
- CTRI/2023/10/058645
- Lead Sponsor
- Poorani A E
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion criteria for Smoker individuals:1. patients with Healed Ridge(6 months of extraction postoperatively) [Group I and Group III]2. patients with Fresh Extracted Socket [Group II and group IV].3. Non Smoker patients that include who have never smoked [Group I and group II].4. Patients who are between 25-60 years of age.5. Smoker patients that include who have smoke morethan 10 cigrattes per day [Group III and group IV].Inclusion criteria for Non Smoker individuals:1. patients with Healed Ridge(6 months of extraction postoperatively) [Group I and Group III].2. patients with Fresh Extracted Socket [Group II and group IV].3. Non Smoker patients that include who have never smoked [Group I and group II].
Exclusion criteria for Smoker individuals:
1. History of oral /intravenous bisphosphonate use for >3 years.
2. Pregnancy or lactation
3. Known allergy to any material or medication used in the study.
4. Any Previous History of head and neck radiation therapy
5. Chemotherapy in the last 12 months
6. Severe psychologic problems
7. Patient not willing to sign the consent approved by the Human Studies Committee.
Exclusion criteria for Non smoker individuals:
1.Smokers.
2.History of oral /intravenous bisphosphonate use for >3 years
3.Pregnancy or lactation
4.Known allergy to any material or medication used in the study.
5.Any Previous History of head and neck radiation therapy
6.Chemotherapy in the last 12 months
7.Severe psychologic problems
8.Patient not willing to sign the consent approved by the Human Studies Committee.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the secondary stability using resonance frequency analyser and crestal bone levels in the Non Smoker and Smoker individuals <br/ ><br>Timepoint: Baseline <br/ ><br>4 week <br/ ><br>8 week <br/ ><br>12 week <br/ ><br>16 week
- Secondary Outcome Measures
Name Time Method To assess the papillary height,pink esthetic score,assessment of pain and wound healing index in Non smokers and smokers individuals. <br/ ><br> <br/ ><br>Timepoint: Baseline <br/ ><br>4 week <br/ ><br>8 week <br/ ><br>12 week <br/ ><br>16 week;To evaluate the primary stability using Resonance Frequency Analyser in smoker and non smokers individuals. <br/ ><br>Timepoint: Baseline